- CIIX’s wholly owned foreign enterprise, CBD Biotechnology Co. Ltd. (CBD Biotech), will debut new private label wine at peak period for liquor sales in China
- Company recorded sales of $2.35 million for FY2018, up 41 percent from $1.66 million the prior year
- Summer Yun, CEO of CBD Biotech, anticipates greater volume during the top sales season for liquor
ChineseInvestors.com, Inc.’s (OTCQB: CIIX) CBD Biotech, a wholly owned foreign enterprise, plans to debut a CBD hemp-infused rice wine in December, during China’s peak holiday/festival season that includes Christmas, New Year’s, and Spring Festival (http://cnw.fm/cq9AQ).
In a news release, Warren Wang, CEO of CIIX, said, “Moving forward, CBD Biotech plans to explore a variety of hemp products, in addition to its skin-care and alcoholic beverage products. We believe the upcoming launch of CBD Hemp Wine will serve as a strong sales driver for the Company.”
The announcement comes after CIIX reported a sharp jump in its sales for FY 2018. Prior, CIIX also detailed plans to spin off its CBD division in the future. The division includes CBD Biotech, Hemp Logic, Inc. and ChineseHempOil.com, Inc. (http://cnw.fm/0DQ0g).
CIIX has an international Chinese-speaking audience. It has core revenue from subscriptions and consulting. Its website notes that the company expects to issue its own ICO in the second half of 2018 or in 2019 and create a virtual investment ‘ecosystem’ for its Chinese viewers (http://cnw.fm/0rRIo). Internationally, its future network of ATMs may expand into Canada from the U.S., and its bitcoin courses may be offered online to Asia.
An update note issued by SeeThruEquity last month explained that CIIX was seeking some $3 million in a private placement in August. Its analysis expects that CIIX will continue to seek external capital to cover operating costs (http://cnw.fm/49VwC).
For more information, visit the company’s website at www.ChineseInvestors.com
More from CannabisNewsWire
About CBDWire
CBDWire (CBDW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CBDNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CBDW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CBDW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CBDW brings its clients unparalleled visibility, recognition and brand awareness. CBDW is where news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.cbdwire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
CBDWire (CBDW)
Denver, Colorado
cbdwire.com
303.498.7722 Office
Editor@CBDWire.com
